Teva Pharmaceuticals (TEVA)

• Market cap: $37.6B
• 1 day: 2.44%
• 5 days: 3.67%
• 1 month: 10.07%
• 3 months: 63.79%
• 6 months: 99.7%
• Year to date: 5.95%
• 1 year: 60.42%
• 5 years: 179.78%
• 10 years: -49.08%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Employees: 35,686